Clinical Trials Logo

Clinical Trial Summary

Background The current Danish National Guideline for treatment of pyogenic vertebral osteomyelitis (PVO) recommends 6 weeks antibiotic (AB) treatment, with a 2-week intravenous (IV) AB lead-in followed by 4 weeks oral AB for uncomplicated PVO, and 12 weeks AB treatment with a 2-4-week IV AB lead-in followed by 8 weeks oral AB for complicated PVO. The primary objective of the current study is to investigate whether shortening the duration of IV AB to one week for both complicated and uncomplicated PVO is non-inferior to the current Danish National Guideline.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06250023
Study type Observational
Source Rigshospitalet, Denmark
Contact Anne-Mette Lebech, MD
Phone +4535458622
Email anne-mette.lebech@regionh.dk
Status Recruiting
Phase
Start date February 1, 2024
Completion date October 2026